Breadcrumbs Section. Click here to navigate to respective pages.
Book

Book
Pharmacoepidemiology
DOI link for Pharmacoepidemiology
Pharmacoepidemiology book
Pharmacoepidemiology
DOI link for Pharmacoepidemiology
Pharmacoepidemiology book
Get Citation
ABSTRACT
This volume is comprised of papers presented at the Third International Conference on Pharmacoepidemiology, held September 9-11, 1987, in Minneapolis, Minnesota. The book is divided into four sections, which reflect the four themes of the conference: Social Impact of Pharmacoepidemiology; Drug Epidemiology and the Law; Drug Surveillance; and Drugs, Populations, and Outcomes: Specific Studies. The collection of papers discusses the social and legal impact of epidemiology, the system of checks and balances that is necessary for the field, the importance of core support for researchers, and the goal of an enlightened and informed public, including the media, consumer advocates, and the courts. Contributing authors offer perspectives from academia, practice, government, industry and the law. Numerous tables and figures are included to illustrate many of the papers within the text. This book offers substantial reading for epidemiologists and individuals interested in the field of pharmacoepidemiology.
TABLE OF CONTENTS
section One|50 pages
Social Impact of Pharmacoepidemiology
chapter 2|19 pages
Risk Assessment of New Drugs, Pharmacoepidemiology, and Regulatory Decisionmaking
chapter 3|7 pages
Industry Perspectives and the Contributions of Pharmacoepidemiology to Public Health
section Two|66 pages
Drug Epidemiology and the Law
chapter 4|31 pages
Impact of Drug Products Liability on Needs for Pharmacoepidemiologic Studies and Expertise
chapter 5|30 pages
Epidemiology in the Courtroom: Anatomy of an Intellectual Embarrassment
section Three|108 pages
Drug Surveillance
chapter 6|12 pages
A Brief Review of the Yellow Card Adverse Reaction Reporting Scheme in the United Kingdom
chapter 7|11 pages
Frequency Analysis of Spontaneous Reports from Different Countries: The Example of Continental Western Europe
chapter 8|10 pages
Evaluation of First Year Experience of a State Pilot Project to Promote Physician Reporting of Adverse Drug Events to the Food and Drug Administration
chapter 9|7 pages
Monitoring System for Adverse Events Following Immunization: Risk Factors for Convulsions After Vaccination
chapter 10|7 pages
Application of a New Method for Adverse Experience Monitoring to Premarketing Studies on Two New Drugs: Some Experiences
chapter 12|6 pages
The Pharmacoepidemiology Data Base of the Brigham and Women’s Hospital
chapter 13|10 pages
Overcoming Limitations of Routine Surveillance of Drug Overdose
chapter 16|8 pages
Postmarketing Surveillance in Tayside: A Further Assessment of Record Linkage Using Five Nonsteroidal Antiinflammatory Drugs
section Four|128 pages
Drugs, Populations, and Outcomes: Specific Studies